Genialis

Genialis company information, Employees & Contact Information

Explore related pages

Related company profiles:

Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data.
Looking for a particular Genialis employee's phone or email?

Genialis Questions

News

Genialis and Cleveland Clinic Collaborate to Develop AI-Powered Biomarkers that Improve Pancreatic Cancer Care - Business Wire

Genialis and Cleveland Clinic Collaborate to Develop AI-Powered Biomarkers that Improve Pancreatic Cancer Care Business Wire

Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes - Inside Precision Medicine

Genialis Uses Machine Learning to Personalize Cancer Treatment Outcomes Inside Precision Medicine

Tempus AI Stock Falls Despite Collaboration Announcement With Genialis - Yahoo Finance

Tempus AI Stock Falls Despite Collaboration Announcement With Genialis Yahoo Finance

Genialis: Machine Learning-Driven Biomarker Discovery In An Over $15 Billion Market - Pulse 2.0

Genialis: Machine Learning-Driven Biomarker Discovery In An Over $15 Billion Market Pulse 2.0

Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response - Business Wire

Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response Business Wire

Genialis Launches krasID, a First in KRAS Inhibitor Testing for Drug Development - Inside Precision Medicine

Genialis Launches krasID, a First in KRAS Inhibitor Testing for Drug Development Inside Precision Medicine

Cell-intrinsic glial pathology is conserved across human and murine models of Huntington’s disease - ScienceDirect.com

Cell-intrinsic glial pathology is conserved across human and murine models of Huntington’s disease ScienceDirect.com

AI in Healthcare: Biopharmaceutical Applications - BioProcess International

AI in Healthcare: Biopharmaceutical Applications BioProcess International

Development and validation of a simplified method to generate human microglia from pluripotent stem cells - Molecular Neurodegeneration

Development and validation of a simplified method to generate human microglia from pluripotent stem cells Molecular Neurodegeneration

Top Genialis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant